$FIXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Homology Medicines, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Homology Medicines, Inc.. Get notifications about new insider transactions in Homology Medicines, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | FIXX | Homology Medicines ... | Gregory Richard J. | Director | Option Exercise | A | 7.26 | 18,000 | 130,680 | 18,000 | |
| Jun 22 2021 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 7.26 | 18,000 | 130,680 | 18,000 | |
| Jun 22 2021 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 7.26 | 18,000 | 130,680 | 18,000 | |
| Apr 09 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | Chief Operating Off ... | Option Exercise | A | 7.18 | 10,000 | 71,800 | 10,000 | |
| Apr 09 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | Chief Operating Off ... | Option Exercise | A | 7.18 | 10,000 | 71,800 | 10,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | A | 13.78 | 65,000 | 895,700 | 65,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Smith W Bradford | CFO & Treasurer | Option Exercise | M | 0.64 | 13,500 | 8,640 | 101,904 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Smith W Bradford | CFO & Treasurer | Option Exercise | A | 0.00 | 20,000 | 0 | 20,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Smith W Bradford | CFO & Treasurer | Option Exercise | A | 13.78 | 122,000 | 1,681,160 | 122,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Smith W Bradford | CFO & Treasurer | Sell | S | 14.25 | 13,500 | 192,425 | 0 | 13.5 K to 0 (-100.00 %) |
| Feb 09 2021 | FIXX | Homology Medicines ... | Smith W Bradford | CFO & Treasurer | Buy | M | 0.64 | 13,500 | 8,640 | 13,500 | 0 to 13.5 K |
| Feb 09 2021 | FIXX | Homology Medicines ... | Cohn Gabriel | Chief Medical Offic ... | Option Exercise | A | 0.00 | 13,000 | 0 | 13,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | Cohn Gabriel | Chief Medical Offic ... | Option Exercise | A | 13.78 | 78,000 | 1,074,840 | 78,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 0.00 | 42,000 | 0 | 42,000 | |
| Feb 09 2021 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 13.78 | 254,000 | 3,500,120 | 254,000 | |
| Feb 05 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | M | 6.63 | 500 | 3,316 | 44,500 | |
| Feb 05 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Sell | S | 13.00 | 500 | 6,500 | 0 | 500 to 0 (-100.00 %) |
| Feb 05 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Buy | M | 6.63 | 500 | 3,316 | 500 | 0 to 500 |
| Jan 14 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | M | 6.63 | 500 | 3,316 | 45,000 | |
| Jan 14 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Sell | S | 13.00 | 500 | 6,500 | 0 | 500 to 0 (-100.00 %) |
| Jan 14 2021 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Buy | M | 6.63 | 500 | 3,316 | 500 | 0 to 500 |
| Jan 08 2021 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 12.05 | 5,103 | 61,469 | 129,017 | 134.1 K to 129 K (-3.80 %) |
| Jan 08 2021 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 12.06 | 9,897 | 119,395 | 134,120 | 144 K to 134.1 K (-6.87 %) |
| Jan 07 2021 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 11.44 | 10,000 | 114,422 | 144,017 | 154 K to 144 K (-6.49 %) |
| Dec 28 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 12.82 | 20,000 | 256,400 | 181,435 | 201.4 K to 181.4 K (-9.93 %) |
| Dec 28 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 12.82 | 480,000 | 6,153,600 | 4,354,484 | 4.8 M to 4.4 M (-9.93 %) |
| Dec 28 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 12.82 | 20,000 | 256,400 | 181,435 | 201.4 K to 181.4 K (-9.93 %) |
| Dec 28 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 12.82 | 480,000 | 6,153,600 | 4,354,484 | 4.8 M to 4.4 M (-9.93 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 11.88 | 13,703 | 162,792 | 201,435 | 215.1 K to 201.4 K (-6.37 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 13.06 | 6,297 | 82,244 | 215,138 | 221.4 K to 215.1 K (-2.84 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 11.88 | 328,862 | 3,906,881 | 4,834,484 | 5.2 M to 4.8 M (-6.37 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 13.06 | 151,138 | 1,973,998 | 5,163,346 | 5.3 M to 5.2 M (-2.84 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 11.88 | 13,703 | 162,792 | 201,435 | 215.1 K to 201.4 K (-6.37 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.06 | 6,297 | 82,244 | 215,138 | 221.4 K to 215.1 K (-2.84 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 11.88 | 328,862 | 3,906,881 | 4,834,484 | 5.2 M to 4.8 M (-6.37 %) |
| Dec 16 2020 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 13.06 | 151,138 | 1,973,998 | 5,163,346 | 5.3 M to 5.2 M (-2.84 %) |
| Jul 21 2020 | FIXX | Homology Medicines ... | Poulton Jeffrey V. | Director | Option Exercise | A | 16.48 | 36,000 | 593,280 | 36,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | REICIN ALISE | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | Gregory Richard J. | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Jun 12 2020 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | A | 16.32 | 18,000 | 293,760 | 18,000 | |
| Mar 18 2020 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Sell | S | 13.01 | 1,315 | 17,109 | 0 | 1.3 K to 0 (-100.00 %) |
| Feb 05 2020 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 12,000 | 7,680 | 103,404 | |
| Feb 05 2020 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 16.16 | 12,000 | 193,866 | 0 | 12 K to 0 (-100.00 %) |
| Feb 05 2020 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.63 | 12,000 | 7,579 | 12,000 | 0 to 12 K |
| Feb 05 2020 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.16 | 12,500 | 202,021 | 77,505 | 90 K to 77.5 K (-13.89 %) |
| Jan 31 2020 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 15.45 | 509,970 | 7,879,037 | 0 | 510 K to 0 (-100.00 %) |
| Jan 31 2020 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 15.45 | 8,857 | 136,808 | 509,970 | 518.8 K to 510 K (-1.71 %) |
| Jan 29 2020 | FIXX | Homology Medicines ... | Gregory Richard J. | Director | Option Exercise | M | 0.03 | 10,806 | 324 | 0 | |
| Jan 29 2020 | FIXX | Homology Medicines ... | Gregory Richard J. | Director | Buy | M | 0.03 | 10,806 | 324 | 10,806 | 0 to 10.8 K |
| Jan 28 2020 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 15.51 | 65,891 | 1,021,936 | 518,827 | 584.7 K to 518.8 K (-11.27 %) |
| Jan 28 2020 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 15.77 | 193,359 | 3,049,600 | 584,718 | 778.1 K to 584.7 K (-24.85 %) |
| Jan 28 2020 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 15.69 | 380,256 | 5,965,000 | 778,077 | 1.2 M to 778.1 K (-32.83 %) |
| Jan 03 2020 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 20.50 | 12,500 | 256,191 | 90,005 | 102.5 K to 90 K (-12.19 %) |
| Jan 03 2020 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 20.50 | 9,133 | 187,216 | 154,017 | 163.2 K to 154 K (-5.60 %) |
| Jan 03 2020 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 115,404 | |
| Jan 03 2020 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 20.50 | 6,000 | 122,984 | 0 | 6 K to 0 (-100.00 %) |
| Jan 03 2020 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.63 | 6,000 | 3,790 | 6,000 | 0 to 6 K |
| Dec 27 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.95 | 151,233 | 3,319,579 | 1,766,106 | 1.9 M to 1.8 M (-7.89 %) |
| Dec 27 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.95 | 198,767 | 4,362,956 | 2,321,199 | 2.5 M to 2.3 M (-7.89 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 56,595 | 1,235,435 | 1,917,339 | 2 M to 1.9 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 74,384 | 1,623,758 | 2,519,966 | 2.6 M to 2.5 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 9,130 | 196,297 | 1,973,934 | 2 M to 2 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 11,999 | 257,981 | 2,594,350 | 2.6 M to 2.6 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 5,454 | 118,219 | 1,983,064 | 2 M to 2 M (-0.27 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 7,168 | 155,371 | 2,606,349 | 2.6 M to 2.6 M (-0.27 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 56,595 | 1,235,435 | 1,917,339 | 2 M to 1.9 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 74,384 | 1,623,758 | 2,519,966 | 2.6 M to 2.5 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 9,130 | 196,297 | 1,973,934 | 2 M to 2 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 11,999 | 257,981 | 2,594,350 | 2.6 M to 2.6 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 5,454 | 118,219 | 1,983,064 | 2 M to 2 M (-0.27 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 7,168 | 155,371 | 2,606,349 | 2.6 M to 2.6 M (-0.27 %) |
| Dec 13 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 19.92 | 358,000 | 7,131,360 | 358,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Cohn Gabriel | Chief Medical Offic ... | Option Exercise | A | 19.92 | 15,000 | 298,800 | 15,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Option Exercise | A | 19.92 | 110,000 | 2,191,200 | 110,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | A | 19.92 | 112,000 | 2,231,040 | 112,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | A | 19.92 | 111,000 | 2,211,120 | 111,000 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Cohn Gabriel | Chief Medical Offic ... | Option Exercise | A | 17.14 | 120,000 | 2,056,800 | 120,000 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 121,404 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 127,404 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 16.21 | 6,000 | 97,266 | 0 | 6 K to 0 (-100.00 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 16.00 | 6,000 | 96,000 | 0 | 6 K to 0 (-100.00 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Dec 03 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.25 | 12,500 | 203,176 | 102,505 | 115 K to 102.5 K (-10.87 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.04 | 12,500 | 200,559 | 115,005 | 127.5 K to 115 K (-9.80 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 16.23 | 9,300 | 150,970 | 163,150 | 172.5 K to 163.2 K (-5.39 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 16.06 | 9,300 | 149,390 | 172,450 | 181.8 K to 172.5 K (-5.12 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 133,404 | |
| Oct 02 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 18.23 | 100 | 1,823 | 0 | 100 to 0 (-100.00 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 17.38 | 5,900 | 102,544 | 100 | 6 K to 100 (-98.33 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Oct 02 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 18.23 | 100 | 1,823 | 127,505 | 127.6 K to 127.5 K (-0.08 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 17.39 | 12,400 | 215,645 | 127,605 | 140 K to 127.6 K (-8.86 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 18.23 | 100 | 1,823 | 181,750 | 181.9 K to 181.8 K (-0.05 %) |
| Oct 02 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 17.38 | 9,200 | 159,936 | 181,850 | 191.1 K to 181.9 K (-4.82 %) |
| Sep 09 2019 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Sell | S | 19.94 | 1,166 | 23,251 | 0 | 1.2 K to 0 (-100.00 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 139,404 | |
| Sep 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 18.74 | 6,000 | 112,419 | 0 | 6 K to 0 (-100.00 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Sep 05 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 18.74 | 9,300 | 174,284 | 191,050 | 200.4 K to 191.1 K (-4.64 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 18.75 | 12,500 | 234,320 | 140,005 | 152.5 K to 140 K (-8.20 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 139,404 | |
| Sep 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 18.74 | 6,000 | 112,419 | 0 | 6 K to 0 (-100.00 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Sep 05 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 18.74 | 9,300 | 174,284 | 191,050 | 200.4 K to 191.1 K (-4.64 %) |
| Sep 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 18.75 | 12,500 | 234,320 | 140,005 | 152.5 K to 140 K (-8.20 %) |
| Aug 05 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 17.37 | 9,300 | 161,523 | 200,350 | 209.7 K to 200.4 K (-4.44 %) |
| Aug 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 145,404 | |
| Aug 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 17.37 | 6,000 | 104,191 | 0 | 6 K to 0 (-100.00 %) |
| Aug 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Aug 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 17.37 | 12,500 | 217,111 | 152,505 | 165 K to 152.5 K (-7.58 %) |
| Jul 15 2019 | FIXX | Homology Medicines ... | REICIN ALISE | Director | Option Exercise | A | 19.25 | 31,160 | 599,830 | 31,160 | |
| Jul 11 2019 | FIXX | Homology Medicines ... | Rasty Siyamak | Chief Operating Off ... | Sell | S | 20.00 | 8,000 | 160,000 | 222,707 | 230.7 K to 222.7 K (-3.47 %) |
| Jul 03 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 19.56 | 100 | 1,956 | 209,650 | 209.8 K to 209.7 K (-0.05 %) |
| Jul 03 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 18.98 | 9,200 | 174,583 | 209,750 | 219 K to 209.8 K (-4.20 %) |
| Jul 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 151,404 | |
| Jul 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 19.00 | 6,000 | 113,971 | 0 | 6 K to 0 (-100.00 %) |
| Jul 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Jun 11 2019 | FIXX | Homology Medicines ... | Flynn James E | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | Gregory Richard J. | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | Wheeler Cameron | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | Thistle Mary | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | Patterson Matthew R | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 10 2019 | FIXX | Homology Medicines ... | GILLIS STEVEN | Director | Option Exercise | A | 19.51 | 15,580 | 303,966 | 15,580 | |
| Jun 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 157,404 | |
| Jun 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 19.94 | 6,000 | 119,664 | 0 | 6 K to 0 (-100.00 %) |
| Jun 05 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Jun 05 2019 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Sell | S | 20.00 | 1,288 | 25,765 | 0 | 1.3 K to 0 (-100.00 %) |
| Jun 05 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 19.90 | 9,300 | 185,093 | 218,950 | 228.3 K to 219 K (-4.07 %) |
| Jun 05 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 19.86 | 12,500 | 248,263 | 177,505 | 190 K to 177.5 K (-6.58 %) |
| Jun 05 2019 | FIXX | Homology Medicines ... | Rasty Siyamak | Chief Operating Off ... | Sell | S | 20.22 | 8,000 | 161,778 | 230,707 | 238.7 K to 230.7 K (-3.35 %) |
| May 23 2019 | FIXX | Homology Medicines ... | ARCH Venture Fund VIII, L.P. | 10% Owner | Sell | J | 0.00 | 300,001 | 0 | 5,768,694 | 6.1 M to 5.8 M (-4.94 %) |
| May 20 2019 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 21.47 | 24,600 | 528,162 | 221,435 | 246 K to 221.4 K (-10.00 %) |
| May 20 2019 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 21.47 | 590,400 | 12,675,888 | 5,314,484 | 5.9 M to 5.3 M (-10.00 %) |
| May 20 2019 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 21.47 | 24,600 | 528,162 | 221,435 | 246 K to 221.4 K (-10.00 %) |
| May 20 2019 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 21.47 | 590,400 | 12,675,888 | 5,314,484 | 5.9 M to 5.3 M (-10.00 %) |
| Apr 15 2019 | FIXX | Homology Medicines ... | Flynn James E | Director | Buy | P | 22.50 | 533,333 | 11,999,993 | 1,158,333 | 625 K to 1.2 M (+85.33 %) |
| Dec 18 2018 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Option Exercise | A | 24.28 | 74,000 | 1,796,720 | 74,000 | |
| Dec 18 2018 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | A | 24.28 | 66,000 | 1,602,480 | 66,000 | |
| Dec 18 2018 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 24.28 | 203,000 | 4,928,840 | 203,000 | |
| Dec 18 2018 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | A | 24.28 | 88,000 | 2,136,640 | 88,000 | |
| Dec 12 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 26.01 | 623 | 16,201 | 246,035 | 246.7 K to 246 K (-0.25 %) |
| Dec 12 2018 | FIXX | Homology Medicines ... | 5AM Ventures IV, L.P. | 10% Owner | Sell | S | 26.01 | 14,952 | 388,828 | 5,904,884 | 5.9 M to 5.9 M (-0.25 %) |
| Dec 12 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 26.01 | 623 | 16,201 | 246,035 | 246.7 K to 246 K (-0.25 %) |
| Dec 12 2018 | FIXX | Homology Medicines ... | PARMAR KUSH | Director | Sell | S | 26.01 | 14,952 | 388,828 | 5,904,884 | 5.9 M to 5.9 M (-0.25 %) |